Patrick Donnelly
Stock Analyst at Citigroup
(4.15)
# 561
Out of 4,412 analysts
193
Total ratings
59.44%
Success rate
9.27%
Average return
Main Sectors:
28 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Maintains: Buy | $280 → $290 | $246.58 | +17.61% | 8 | Apr 24, 2024 | |
| DGX Quest Diagnostics | Maintains: Neutral | $135 → $145 | $134.26 | +8.00% | 7 | Apr 24, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $100 | $58.85 | +69.92% | 9 | Apr 3, 2024 | |
| SHC Sotera Health Company | Upgrades: Buy | $18 → $16 | $11.40 | +40.35% | 2 | Apr 3, 2024 | |
| HOLX Hologic | Upgrades: Buy | $80 → $95 | $75.98 | +25.03% | 8 | Apr 3, 2024 | |
| BIO Bio-Rad Laboratories | Downgrades: Neutral | $400 → $365 | $275.94 | +32.28% | 9 | Apr 3, 2024 | |
| TMO Thermo Fisher | Reinstates: Neutral | $620 | $573.60 | +8.09% | 16 | Mar 18, 2024 | |
| A Agilent Technologies | Maintains: Neutral | $130 → $145 | $137.74 | +5.27% | 14 | Feb 28, 2024 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $215 → $250 | $229.03 | +9.16% | 10 | Feb 15, 2024 | |
| AVTR Avantor | Maintains: Buy | $24 → $30 | $23.94 | +25.31% | 6 | Feb 15, 2024 | |
| BRKR Bruker | Maintains: Buy | $80 → $95 | $80.97 | +17.33% | 6 | Feb 14, 2024 | |
| QGEN Qiagen | Maintains: Buy | $62 → $60 | $41.65 | +44.06% | 13 | Feb 8, 2024 | |
| ILMN Illumina | Upgrades: Neutral | $85 → $120 | $122.28 | -1.86% | 8 | Dec 11, 2023 | |
| FTRE Fortrea Holdings | Upgrades: Buy | $34 → $40 | $36.35 | +10.04% | 2 | Dec 11, 2023 | |
| WAT Waters | Maintains: Neutral | $265 → $300 | $311.30 | -3.63% | 14 | Dec 11, 2023 | |
| QDEL QuidelOrtho | Downgrades: Neutral | $95 → $72 | $39.64 | +81.63% | 3 | Dec 11, 2023 | |
| OSUR OraSure Technologies | Maintains: Buy | $7 → $9 | $5.32 | +69.17% | 4 | Dec 11, 2023 | |
| MTD Mettler-Toledo International | Downgrades: Sell | $1,050 → $975 | $1,238.09 | -21.25% | 3 | Dec 11, 2023 | |
| IQV IQVIA Holdings | Maintains: Neutral | $190 → $225 | $234.88 | -4.21% | 7 | Dec 11, 2023 | |
| ICLR ICON PLC | Maintains: Buy | $300 → $315 | $308.31 | +2.17% | 7 | Dec 11, 2023 | |
| TECH Bio-Techne | Maintains: Buy | $100 → $80 | $64.06 | +24.88% | 7 | Nov 1, 2023 | |
| GH Guardant Health | Reiterates: Buy | $50 | $17.35 | +188.18% | 7 | Oct 2, 2023 | |
| SERA Sera Prognostics | Maintains: Neutral | $3.75 → $2.75 | $10.75 | -74.42% | 4 | Aug 10, 2023 | |
| TXG 10x Genomics | Maintains: Buy | $65 → $75 | $27.59 | +171.84% | 8 | Aug 4, 2023 | |
| STVN Stevanato Group | Maintains: Buy | $30 → $35 | $27.54 | +27.09% | 3 | May 5, 2023 | |
| LH Laboratory Corporation of America Holdings | Maintains: Neutral | $250 → $260 | $198.40 | +31.05% | 3 | Feb 17, 2023 | |
| PSNL Personalis | Maintains: Buy | $8 → $6 | $1.27 | +374.31% | 4 | Nov 3, 2022 | |
| MYGN Myriad Genetics | Upgrades: Neutral | n/a | $18.18 | - | 1 | Nov 30, 2018 |
Danaher
Apr 24, 2024
Maintains: Buy
Price Target: $280 → $290
Current: $246.58
Upside: +17.61%
Quest Diagnostics
Apr 24, 2024
Maintains: Neutral
Price Target: $135 → $145
Current: $134.26
Upside: +8.00%
Exact Sciences
Apr 3, 2024
Maintains: Buy
Price Target: $100
Current: $58.85
Upside: +69.92%
Sotera Health Company
Apr 3, 2024
Upgrades: Buy
Price Target: $18 → $16
Current: $11.40
Upside: +40.35%
Hologic
Apr 3, 2024
Upgrades: Buy
Price Target: $80 → $95
Current: $75.98
Upside: +25.03%
Bio-Rad Laboratories
Apr 3, 2024
Downgrades: Neutral
Price Target: $400 → $365
Current: $275.94
Upside: +32.28%
Thermo Fisher
Mar 18, 2024
Reinstates: Neutral
Price Target: $620
Current: $573.60
Upside: +8.09%
Agilent Technologies
Feb 28, 2024
Maintains: Neutral
Price Target: $130 → $145
Current: $137.74
Upside: +5.27%
Charles River Laboratories International
Feb 15, 2024
Maintains: Neutral
Price Target: $215 → $250
Current: $229.03
Upside: +9.16%
Avantor
Feb 15, 2024
Maintains: Buy
Price Target: $24 → $30
Current: $23.94
Upside: +25.31%
Bruker
Feb 14, 2024
Maintains: Buy
Price Target: $80 → $95
Current: $80.97
Upside: +17.33%
Qiagen
Feb 8, 2024
Maintains: Buy
Price Target: $62 → $60
Current: $41.65
Upside: +44.06%
Illumina
Dec 11, 2023
Upgrades: Neutral
Price Target: $85 → $120
Current: $122.28
Upside: -1.86%
Fortrea Holdings
Dec 11, 2023
Upgrades: Buy
Price Target: $34 → $40
Current: $36.35
Upside: +10.04%
Waters
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $311.30
Upside: -3.63%
QuidelOrtho
Dec 11, 2023
Downgrades: Neutral
Price Target: $95 → $72
Current: $39.64
Upside: +81.63%
OraSure Technologies
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $5.32
Upside: +69.17%
Mettler-Toledo International
Dec 11, 2023
Downgrades: Sell
Price Target: $1,050 → $975
Current: $1,238.09
Upside: -21.25%
IQVIA Holdings
Dec 11, 2023
Maintains: Neutral
Price Target: $190 → $225
Current: $234.88
Upside: -4.21%
ICON PLC
Dec 11, 2023
Maintains: Buy
Price Target: $300 → $315
Current: $308.31
Upside: +2.17%
Bio-Techne
Nov 1, 2023
Maintains: Buy
Price Target: $100 → $80
Current: $64.06
Upside: +24.88%
Guardant Health
Oct 2, 2023
Reiterates: Buy
Price Target: $50
Current: $17.35
Upside: +188.18%
Sera Prognostics
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $10.75
Upside: -74.42%
10x Genomics
Aug 4, 2023
Maintains: Buy
Price Target: $65 → $75
Current: $27.59
Upside: +171.84%
Stevanato Group
May 5, 2023
Maintains: Buy
Price Target: $30 → $35
Current: $27.54
Upside: +27.09%
Laboratory Corporation of America Holdings
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $198.40
Upside: +31.05%
Personalis
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $1.27
Upside: +374.31%
Myriad Genetics
Nov 30, 2018
Upgrades: Neutral
Price Target: n/a
Current: $18.18
Upside: -